JPMorgan raises Alkem target price to ₹6,100, maintains Neutral rating
after close1 source ↓written by the desknot a recommendation
- target price
- ₹6,100
- ₹5,900
- against the current
- 13.6%
- market price
- ₹5,368
- US sales grew
- 6.5%
JPMorgan has maintained a Neutral rating on Alkem Laboratories, raising its target price to ₹6,100 from ₹5,900. This implies an upside of 13.6% against the current market price of ₹5,368. While US sales grew 6.5%, non-US sales surged 35% year-on-year, indicating a shift in growth dynamics.
Not investment advice. For informational purposes only.